Company Email Format Management

Iksuda Therapeutics

Biotechnology Research Newcastle Helix, United Kingdom 44 employees

Employees: 44
Contacts: 1
Emails: 1
Phones: 1

glythera.com LinkedIn Crunchbase

Iksuda Therapeutics Overview

Headquarters: Newcastle Helix, United Kingdom
Phone Number: Available in AeroLeads
Website: glythera.com
Industry: Biotechnology Research
Employees: 44
Funding: 47.0M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Antibody-Drug Conjugates PermaLink™ Conjugation Chemistry Cancer research ADCs Drug Development Therapeutics Antibodies Toxins Cancer Treatment ADC Stability Antibody Drug Conjugate

About Iksuda Therapeutics

Through our highly experienced ADC Research & Development Team, we are building a pipeline of class-leading ADCs with superior therapeutic index (TI) for difficult-to-treat cancers. Our approach is to develop the best ADC for any given target or tumor sub-type rather than 'technology-driven ADCs'. All our ADCs incorporate tumor-selective release & activation of the most relevant payload according to mechanism, optimizing anti-cancer efficacy and enhancing patient safety.

Iksuda Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 1
Email contacts: 1; 25.0% coverage
Phone contacts: 1; 25.0% coverage

Iksuda Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
David Simpson	CEO - Board Director - Advisor	Rowlands Gill, England, United Kingdom	Email Phone
Simon Frost	Cmc & Research Alliance Manager at Iksuda Therapeutics		View
Susan Sullivan		West Newton, Massachusetts, United States	View
Ian Evetts	Chief Business Officer Iksuda Therapeutics - Managing Director Atebion Bds - Non-exec Director - Biopharm Consultant		View